Form 4 for HAE HAEMONETICS CORP
Accepted 2023-06-09 00:00:00 ET · period of report 2023-06-07 · accession 0001127602-23-018423 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-06-09 | 2023-06-07 | HAE | Strong Stewart W | Pres, Gbl Hospital | M - OptEx | $56.93 | +6,893 | 24.0K | +40% | +$392.4K |
| D | 2023-06-09 | 2023-06-07 | HAE | Strong Stewart W | Pres, Gbl Hospital | S - Sale+OE | $88.04 | -2,538 | 16.4K | -13% | -$223.4K |
| D | 2023-06-09 | 2023-06-07 | HAE | Strong Stewart W | Pres, Gbl Hospital | F - Tax | $88.00 | -5,053 | 19.0K | -21% | -$444.7K |
| DM | 2023-06-09 | 2023-06-07 | HAE | Strong Stewart W | Pres, Gbl Hospital | M - OptEx | $0.00 | -6,893 | 7,231 | -49% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-07 | M | A | 4,483 | $56.57 | 21,630 | D | — | — | (F1) This number includes unvested restricted stock units ("RSUs") previously reported. |
| 2 | Common | Common Stock | 2023-06-07 | S | D | 2,538 | $88.04 | 16,449 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.96 to $88.12, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this report. (F1) This number includes unvested restricted stock units ("RSUs") previously reported. |
| 3 | Common | Common Stock | 2023-06-07 | F | D | 5,053 | $88.00 | 18,987 | D | — | — | (F2) Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I. (F1) This number includes unvested restricted stock units ("RSUs") previously reported. |
| 4 | Common | Common Stock | 2023-06-07 | M | A | 2,410 | $57.60 | 24,040 | D | — | — | (F1) This number includes unvested restricted stock units ("RSUs") previously reported. |
| 5 | Derivative | Non-qualified Stock Option (Right to Buy) | 2023-06-07 | M | D | 4,483 | $0.00 | 4,483 | D | $56.57 · 2023-05-18 to 2028-05-18 | 4,483 Common Stock | (F4) Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. |
| 6 | Derivative | Non-qualified Stock Option (Right to Buy) | 2023-06-07 | M | D | 2,410 | $0.00 | 7,231 | D | $57.60 · 2023-05-16 to 2029-05-16 | 2,410 Common Stock | (F4) Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. |